The Accuracy of Japanese Administrative Data in Identifying Acute Exacerbation of Idiopathic Pulmonary Fibrosis-Reference-Cited by-同舟云学术

The Accuracy of Japanese Administrative Data in Identifying Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Published:2022 Issue:2 Volume:4 Page:53-62
ISSN:2434-4338
Container-title:Annals of Clinical Epidemiology
language:en
Short-container-title:Ann Clin Epidemiol

Author:

Anan Keisuke¹,Kataoka Yuki²,Ichikado Kazuya³,Kawamura Kodai³,Johkoh Takeshi⁴,Fujimoto Kiminori⁵,Tobino Kazunori⁶,Tachikawa Ryo⁷,Ito Hiroyuki⁸,Nakamura Takahito⁹,Kishaba Tomoo¹⁰,Inomata Minoru¹¹,Yamamoto Yosuke¹

Affiliation:

1. Department of Healthcare Epidemiology, School of Public Health in the Graduate School of Medicine, Kyoto University

2. Department of Internal Medicine, Kyoto Min-Iren Asukai Hospital

3. Division of Respiratory Medicine, Saiseikai Kumamoto Hospital

4. Department of Radiology, Kansai Rosai Hospital

5. Department of Radiology, Kurume University School of Medicine

6. Department of Respiratory Medicine, Iizuka Hospital

7. Department of Respiratory Medicine, Kobe City Medical Center General Hospital

8. Department of Pulmonology, Kameda Medical Center

9. Department of Internal Medicine, Nara Prefecture Seiwa Medical Center

10. Department of Respiratory Medicine, Okinawa Chubu Hospital

11. Department of Respiratory Medicine, Japanese Red Cross Medical Center

Publisher

Society for Clinical Epidemiology

Link

https://www.jstage.jst.go.jp/article/ace/4/2/4_22008/_pdf

Reference24 articles.

1. 1. du Bois RM. An earlier and more confident diagnosis of idiopathic pulmonary fibrosis. Eur Respir Rev 2012;21:141–146.

2. 2. Hutchinson J, Fogarty A, Hubbard R, McKeever T. Global incidence and mortality of idiopathic pulmonary fibrosis: A systematic review. Eur Respir J 2015;46:795–806.

3. 3. Hutchinson JP, McKeever TM, Fogarty AW, Navaratnam V, Hubbard RB. Increasing global mortality from idiopathic pulmonary fibrosis in the twenty-first century. Ann Am Thorac Soc 2014;11:1176–1185.

4. 4. Navaratnam V, Fogarty AW, Glendening R, McKeever T, Hubbard RB. The increasing secondary care burden of idiopathic pulmonary fibrosis: hospital admission trends in England from 1998 to 2010. Chest 2013;143:1078–1084.

5. 5. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2071–2082.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Algorithms Identifying Patients With Acute Exacerbation of Interstitial Pneumonia and Acute Interstitial Lung Diseases Developed Using Japanese Administrative Data;Cureus;2024-01-27

2. Skeletal muscle atrophy and short-term mortality in patients with acute exacerbation of idiopathic pulmonary fibrosis: an observational cohort study;Respiratory Investigation;2023-07

3. Early corticosteroid dose tapering in patients with acute exacerbation of idiopathic pulmonary fibrosis;Respiratory Research;2022-10-26

4. Skeletal muscle atrophy and short-term mortality in patients with acute exacerbation of idiopathic pulmonary fibrosis: An observational cohort study;2022-08-10